Organization · Venture Capital
PMK-Group
PMK-Group is a Singapore-based investment organization focused on early-stage biotech and medtech companies. They provide capital, mentorship, and operational support to help navigate the complexities of clinical development.
Overview
What PMK-Group does
What PMK-Group is
PMK-Group is a Singapore-based investment organization focused on early-stage biotech and medtech companies. They provide capital, mentorship, and operational support to help navigate the complexities of clinical development.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2024
- Approximate age
- About 2 years
- Structured capabilities
- Funder
- Last reviewed
- March 30, 2026
Official channels
Find PMK-Group elsewhere
Open the official website or a supported primary organization account.
Capability profile
PMK-Group as a funder
Investment thesis
PMK-Group focuses on advancing healthcare solutions through investments in biotechnology and medical technology, guiding innovative ideas from concept to market.
Focus narrative
PMK-Group primarily invests in early-stage companies within the biotech and MedTech sectors. Their investment strategy focuses on achieving clinical milestones in 2-3 years, significantly faster than the industry standard. The organization has a global outlook with a concentration in Europe and Asia, particularly in areas such as CNS/neurology, metabolic diseases, aging/longevity, diagnostics, and AI-driven health monitoring.
Value beyond capital
PMK-Group provides capital, mentorship, and access to networks for its portfolio companies. The organization collaborates with partners to support clinical validation of early innovations, helping to reduce risks associated with biotech and MedTech development.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+
- Sectors
- Biotech · Healthcare · AI · Diagnostics
- Regions
- Asia · Europe · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 12
Portfolio context
Notable portfolio companies include: NeuroTherapia (USA): Small molecule therapies for CNS diseases and neuroinflammation. Mitochon Pharmaceuticals (USA): Disease-modifying therapies for aging and neurodegenerative diseases. KompanionCare (France): AI interventions for mental and emotional well-being, particularly for seniors. VRG145 (Hungary): Novel oral treatments for migraine prophylaxis. InnoScreen (Singapore): Early detection platform for various diseases using digital biomarkers. Brain Health Ltd. (Europe and Asia): Neurology and longevity clinics with rapid expansion plans. Yon E Global B.V. (Hungary): Medical device for continuous intravaginal measurement of pH and temperature. CheMOnitor (Singapore & Hungary): AI-powered diagnostic tool for predicting chemotherapy effectiveness in lung cancer patients. Relieve Therapeutics (Singapore): Non-invasive topical pain relief through proprietary drug delivery technology. Astrocyte Pharmaceuticals, Inc. (USA): Drugs for traumatic brain injury, stroke, and concussion recovery. BioVersys AG (Switzerland): Targets multi-drug resistant bacterial infections. Xeno Biosciences Inc. (USA): Treatments for obesity and related diseases. Adiposs SA (Switzerland): Imaging products for early detection of cancer cachexia.
Common questions
What to know about PMK-Group
Upseed classifies PMK-Group under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.